XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net loss $ (4,037,916) $ (2,427,515)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 17,319 12,269
Stock-based compensation expense 246,039 205,151
Changes in assets and liabilities:    
Grant funds receivable 0 (50,520)
Prepaid expenses and other current assets (755,973) (138,368)
Other assets 976,498 0
Accounts payable, accrued expenses and other liabilities (208,839) (1,934,257)
Total adjustments 275,044 (1,905,725)
Net cash used in operating activities (3,762,872) (4,333,240)
Cash flows from investing activities:    
Purchase of equipment 0 (62,186)
Net cash used in investing activities 0 (62,186)
Cash flows from financing activities:    
Net proceeds from sale of common stock and warrants 0 9,229,248
Net proceeds from warrant exercise 0 24
Net cash provided by financing activities 0 9,229,272
Net increase (decrease) in cash and cash equivalents (3,762,872) 4,833,846
Cash and cash equivalents at beginning of period 27,612,732 11,423,870
Cash and cash equivalents at end of period $ 23,849,860 $ 16,257,716